SCHEMBL9868656

SCHEMBL9868656

N=C(NCCCc1c[nH]cn1)NCCSCc1cccc(C(F)(F)F)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 1/20 0.45
NPSR1 Q6W5P4 2/20 0.41
KDM4E B2RXH2 2/20 0.41
HSP90AA1 P07900 1/20 0.41
MAPT P10636 1/20 0.41
DAO P14920 2/20 0.37
TP53 P04637 2/20 0.37
POLB P06746 1/20 0.37
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
HDAC9 Q9UKV0 1/20 0.36
HDAC5 Q9UQL6 1/20 0.36
CYP2D6 P10635 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9865647 0.85 GAA (0.45) KDM4EMAPTTP53POLBCYP2D6
SCHEMBL9868660 0.84 TRPV1 (0.39) TRPV1NPSR1KDM4EHSP90AA1MAPT
SCHEMBL9867267 0.82 LMNA (0.35) KDM4EMAPTDAOTP53CYP2D6
SCHEMBL9876539 0.81 CYP1A2 (0.38) NPSR1DAOCYP2D6CYP1A2CYP3A4
SCHEMBL9867335 0.81 EPHX2 (0.35) DAOALDH1A1LMNA
SCHEMBL9868517 0.80 KMT2A (0.42) NPSR1MAPTPOLBCYP2D6CYP1A2
SCHEMBL9866034 0.80 ALDH1A1 (0.45) KDM4EMAPTPOLBHTTMEN1
SCHEMBL9866537 0.78 SCN5A (0.39) TRPV1NPSR1KDM4EHSP90AA1MAPT
SCHEMBL9866527 0.78 SCN5A (0.39) TRPV1NPSR1KDM4EHSP90AA1MAPT
SCHEMBL9866540 0.78 TRPV1 (0.41) TRPV1NPSR1KDM4EHSP90AA1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5021431-A H-1 antagonist, h-2 agonist for treating hypertension, cardiac disease or arterial occlusion HEUMANN PHARMA GMBH & CO. (DE) 1991-06-04 US disclosed
EP-0199845-B1 IMIDAZOLYLALKYLGUANIDIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM HEUMANN PHARMA GMBH & CO (DE) 1990-08-01 EP disclosed
EP-0199845-A1 Imidazolylalkylguanidin derivatives, process for their preparation and pharmaceutical compositions containing them HEUMANN PHARMA GMBH & CO (DE) 1986-11-05 EP disclosed